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 Summary
  The sternum is an uncommon site for neoplastic involvement and metastases are far commoner 
than primary neoplasms. Of the primary tumours, malignant lesions are more frequent than the 
benign lesions. Early diagnosis and treatment is prudent in such neoplasms not only to halt disease 
progression but also to prevent circulatory compromise resulting from the mass effect on the 
mediastinum. Sound knowledge of neoplasms affecting the sternum and their imaging appearance 
is essential to arrive at an early diagnosis and also to obviate biopsy in cases with classical imaging 
findings. Neoplastic involvement of the sternum is extremely unusual and should be considered 
malignant unless proven otherwise. Imaging may help in arriving at the diagnosis of these lesions, 
together with other factors such as patient's age, type of lesion (lytic/sclerotic or mixed), matrix 
mineralization, multiplicity and involvement of other sites.
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The sternum is a midline bone of the axial skeleton which 
anchors the rib cage. Its haematopoietic marrow provides 
a rich soil for seedling of various haematogenous diseases, 
including malignancies and infections. Virtually all bone 
tumours have predilection for the appendicular skeleton, 
flat bones being a relatively less favoured site. Of the flat 
bones, the sternum is an uncommon site of bone tumours 
with a meagre incidence of 0.65%, contributing to nearly 
15% of chest wall tumours.
Metastases are the most common sternal neoplasms. 
Primary sternal neoplasms, whether benign or malignant, 
are quite rare; however, of these two, the latter are more 
common (Table 1). Not only neoplastic involvement of the 
sternum carries adverse prognostication, but other thera-
peutic implications associated soft tissue component can 
potentially cause mediastinal compression, which may 
prove detrimental due to the consequential SVC syndrome 
and circulatory arrest [1–3].
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• Metastases (most common)
• Multiple myeloma
•  Direct contiguous spread 
from adjacent malignancies- 
mediastinal masses, 






• Langerhan’s cell histiocytosis
Table 1. Classification of sternal neoplasms.
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R E V I E W  A R T I C L E
Imaging Modalities
Traditionally, bone tumours are initially evaluated on plain 
radiographs for their location, pattern of bone destruction, 
matrix mineralization, periosteal reaction and associated 
soft tissue component. However, this modality has limita-
tions in evaluating tumours of the flat bones, especially the 
sternum, as the lesion may not be projected in its entire-
ty due to the superimposition by the surrounding lungs. 
Lateral radiographs may help, especially in distinguishing 
intra- and extra-thoracic lesions. However, plain radiogra-
phy is of limited use in diagnosing small lesions as well as 
in evaluating the intrathoracic extent, which necessitates 
the use of cross-sectional imaging.
Computed tomography (CT) is the modality of choice for 
evaluating sternal lesions due to its inherent high spa-
tial and contrast resolution, along with its multiplanar 
capabilities. It can resolve the limitations of radiography 
by providing excellent anatomical details to the surgeon 
pre-operatively and proves invaluable in determining the 
intrathoracic extent and mediastinal invasion. In certain 
bone tumours, including osteoid osteoma, demonstration of 
tiny radiolucent nidus on CT helps to arrive at the diagno-
sis non-invasively.
MRI promises to be a problem-solving modality in inde-
terminate cases, especially to delineate the exact extent of 
bone involvement and mediastinal invasion. It offers the 
advantage of being a radiation-free modality and may help 
in in-vivo characterization of the tumour in certain cases. 
However, failure to establish the pattern of matrix min-
eralization and type of bone marrow destruction, which 
are the essence of bone tumour diagnosis, limits its util-
ity as the unequivocal modality for evaluation of sternal 
tumours. MRI is superior to CT in determining the medias-
tinal invasion.
Nuclear imaging is usually performed as part of skeletal 
survey in cases of suspected skeletal metastasis. It may 
help in ascertaining the malignant quotient non-invasively; 
however, it is of limited utility in tissue characterization.
Figure 1.  Chondrosarcoma: A 55-year-old male with a midline chest swelling. (A, B): Axial CECT shows a lytic, destructive lesion of the sternum with 
heterogeneously enhancing, lobulated soft tissue causing compression of the right ventricle (arrow) with maintained fat planes. Arc-like 
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This article highlights the imaging findings of sternal neo-
plasms. Knowledge of imaging features may help to narrow 




Chondrosarcoma is the most common malignant tumour of 
the chest wall, including the sternum. A cartilage containing 
tumour, it usually presents in the 4th–6th decade of life with 
a male preponderance (male-to-female ratio of 2: 1). It may 
arise de novo or de-differentiate from a pre-existing exostoses 
or enchondroma. Secondary chondrosarcomas may occur as 
a part of the spectrum of radiation-induced sarcomas (RIS) 
after previous therapeutic irradiation for thoracic, mediasti-
nal and chest wall malignancies. Clinically, it presents as a 
slow-growing, large, midline mass which is usually painless.
On radiographs, the presence of stippled or “rings and arcs” 
pattern of calcifications hints to the chondroid matrix. The 
distribution of calcifications is peripheral (c.f. osteosarco-
ma, vide infra).
On CT, the tumour can be either intramedullary or juxta-
cortical, causing cortical destruction along with the pres-
ence of a large, lobulated, soft tissue component having 
chondroid calcifications (Figure 1). Rapid enlargement 
and large soft tissue component favour malignancy; how-
ever, differentiation from malignant transformation in 
pre-existing exostoses and enchondroma continues to 
remain a dilemma to the radiologist. Myxoid chondrosar-
coma, a rare variant consisting of only soft tissue matrix, 
may be indistinguishable from other soft tissue sarcomas 
on imaging [1,3–6].
Osteosarcomas (OS)
The sternum is an uncommon site for osteosarcomas which 
can be either primary or secondary to prior radiation expo-
sure. As compared to the extremity osteosarcoma, sternal 
OS occurs in slightly older patients with a worse prognosis.
It presents with a rapidly enlarging, painful midline swell-
ing. The lesion can be lytic, sclerotic or mixed (Figure 2). 
Classically, there is lytic permeative bone destruction with 
the presence of heterogeneous soft tissue having osteoid 
matrix characterized by amorphous, cloud-like calcifica-
tions in a central distribution [3,4,7.8].
Ewing’s Sarcoma
Ewing’s sarcoma (EWS) is a malignant, round-cell tumour 
which is variously referred to as Askin’s or primitive neu-
roendocrine tumour. It usually presents in adolescence 
as a painful swelling. It has a high metastatic propensity 
leading to tumoural dissemination to the lungs, bones and 
lymph nodes in nearly one fourth of cases at the time of 
presentation. EWS occurs with a comparable frequency in 
both long (60%) and flat (40%) bones.
Figure 2.  (A–C) Sternal osteosarcoma: Lytic destruction (arrow) of the sternum with the presence of heterogeneously enhancing soft tissue 
showing amorphous calcification (curved arrow) predominantly in the central distribution. Associated soft tissue component is extending 
retro-sternally and invades the anterior mediastinum. Note is made of malignant right pleural effusion (*).
A
CB
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Figure 3.  (A–D) Ewing’s sarcoma: A 15-year-old male with a rapidly developing midline swelling and constitutional symptoms. CECT revealed lytic, 
permeative destruction of the sternum with spiculated (arrow) periosteal reaction. Note the presence of disproportionately large soft 




Figure 4.  Sternal plasmacytoma: (A) Axial bone window images showing a well-defined intramedullary lytic lesion in the body of the sternum. 
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On CT, there is lytic permeative destruction of the involved 
bone which may show expansion (Figure 3). Cortical destruc-
tion and aggressive periosteal reaction may be present. Of all 
the sternal neoplasms, soft tissue component is dispropor-
tionately large for the magnitude of bone destruction [3,4].
Plasmacytoma
Plasmacytoma and multiple myeloma (MM) refer to a 
continuum of clonal proliferations of myeloma cells. In 
plasmacytoma, the process is localized, as opposed to 




Figure 6.  Sternal metastasis (A) Anaplastic thyroid carcinoma (B) soft tissue sarcoma (C, D), carcinoma of the breast.
A B
C D
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Figure 7.  (A, B) Neuroblastoma metastases: Left-sided thoracic neuroblastoma in a 5-year-old child. Bone window shows multiple sclerotic lesions 
in the sternum and vertebrae.
A B
Figure 8.  LCH (A, B): An 8-year-old male with a lytic lesion (arrow) in the sternum causing cortical breach with scant soft tissue lacking any matrix 
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multiple myeloma in which there is a systemic involve-
ment. Plasmacytoma is believed to be a precursor of MM, 
with an average time of conversion of 5 years. It presents 
in the 5th–7th decade of life.
Plasmacytoma and multiple myeloma have a predilection 
for the sternum due to the persistence of hematopoietic 
marrow until late adulthood. The lesions are lytic and may 
be solitary or multiple (Figure 4). Contrary to myeloma 
lesions occurring elsewhere, sternal myeloma may lack the 
characteristic sharply demarcated, non-sclerotic, punched-
out margins. The lesions are usually expansile and cause 
cortical ballooning and destruction with the presence of 
lobulated, soft tissue component lacking any matrix min-
eralization. Distinguishing this imaging appearance from 
lytic expansile metastasis of renal and thyroid malignan-
cies remains a dilemma to the radiologist, as cortical bal-
looning and destruction make imaging differentiation from 
the metastases difficult. Associated extraosseous, soft tis-
sue component is usually scant, multilobulated and lacks 
any mineralization. It may show intrathoracic/mediastinal 
invasion [3,4,9,10].
Lymphoma
Haematological malignancies such as lymphoma may 
involve the sternum, usually secondary to the systemic 
involvement. They generally manifest in the 5th–8th dec-
ade of life. Sternal involvement is usually seen in Non-
Hodgkin’s lymphoma with a very small number of cases of 
Hodgkin’s lymphoma reported so far.
There may be solitary or multiple lesions that may be lytic, 
sclerotic or mixed (Figure 5). Soft tissue component may be 
present [11].
Metastases
Metastases are the most common sternal neoplasms. 
Depending on the primary neoplastic site, both lytic and 
sclerotic deposits may occur, portending an unfavourable 
prognosis. Common primary tumours that may metasta-
size to the sternum include breast, lung, renal and thy-
roid malignancies. Sclerotic metastases, as in the prostatic 
carcinoma, need to be differentiated from enostosis (bone 
island). Bone island has sharply delineated margins. In 
dubious cases, uptake on scintigraphy favours metastases. 
Of the thyroid malignancies, follicular carcinoma has a pro-
pensity for the skeletal metastases in its haematogenous 
dissemination. Uncommonly, de-differentiated neoplasms 
or anaplastic thyroid carcinoma (Figures 6, 7) may metasta-
size to the sternum either haematogeneously or due to the 
contiguous spread.
Chest wall is an important site for renal carcinoma metas-
tases. Classically, renal and thyroid metastases present 
as pulsatile swellings. CT shows a lytic, expansile lesion 
causing cortical ballooning and thinning with associat-
ed enhancing soft tissue component attributed to its high 
vascularity. Other neoplasms, that may show direct ster-
nal invasion, include mediastinal tumours such as thymic 
malignancies, lymphomas, etc. [1,2,4,12,13].
Benign tumours
The sternum is an uncommon location for benign tumours 
with a substantially lower incidence as compared to malig-
nant tumours. Potentially, any benign tumour can occur, 
but common lesions include osteochondroma, enchon-
droma, haemangioma, haemangiopericytoma, fibrous dys-
plasia, osteoid osteoma and Langerhan’s cell histiocytosis 
(Figure 8).
Figure 9.  Sternal haemangioma: (A) axial and (B) sagittal bone window images show lytic lesion in the sternum with a few coarse trabeculae 
within the centre of lesion.
A B
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Haemangioma
Haemangioma is a hamartomatous vascular malformation 
occurring commonly in soft tissues. Osseous haemangioma 
is an extremely rare occurrence and usually involves the 
skull and vertebra.
On CT, sternal haemangioma appears as a sharply demar-
cated, lucent lesion with thickened trabeculae coursing 
from its centre and giving rise to the “spoke wheel or honey 
comb appearance” (Figure 9). In the presence of character-
istic imaging appearance, the lesion is otherwise a “don’t 
touch” skeletal lesion and hence, biopsy can be obviated 
[1,3,14].
Sternal Tumours – Perspective of the Surgeon
As for other bone malignancies, wide local excision is the 
treatment of choice for sternal malignancies in the absence 
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Neoplasm Demography Imaging findings Difference from the extremity neoplasm
1. Chondrosarcoma > 40 years male 
predominance
Lobulated soft tissue mass with 
“ring and arc” calcification s/o 
chondroid matrix in peripheral 
distribution
•  Higher rate of recurrence
•  Slightly younger age group
•  Slow growth, metastatic propensity
•  Larger size at presentation compared to 
the extremity counterparts
2. Osteosarcoma Elderly Lytic, sclerotic or mixed pattern •  Older age group
•  Usually secondary osteosarcoma 
consequent to prior chemo or 
radiotherapy
•  High likelihood of metastasis at the time 
of presentation
•  Poor prognosis
3. Plasmacytoma 5th–7th decade Lytic expansile lesion
4. Ewing’s sarcoma Adolescence •  Slightly older age group
•  More soft tissue component
5. Lymphoma Permeative or moth eaten 
bone destruction with a large 
soft tissue component
Table 2. Distinguishing features of sternal neoplasm.
of distant spread. However, because of the rib anchorage 
for cosmetic reasons, reconstruction is an important con-
sideration. Even with widespread disease, tumour debulk-
ing is done to relieve the mediastinal compression and pain.
Conclusions
Sternal neoplasms are extremely rare; however, aware-
ness of the imaging findings is of utmost importance. The 
neoplasms may be life-threatening not only due to their 
metastasizing potential, but also due to potential medias-
tinal compression that can result in sudden death. Imaging 
characteristics of these neoplasms parallel those of the 
lesions occurring in the extremities, with a certain distinc-
tion (Table 2). Imaging diagnosis is based on a multitude of 
factors including patient age, pattern of bone destruction, 
matrix mineralization all of which may help arrive at the 
diagnosis in certain cases.
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